- Home
- WHLR vs CMND Comparison
WHLR vs CMND Comparison
Compare WHLR & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHLR | CMND |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | Canada |
| Employees | 49 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | WHLR | CMND |
|---|---|---|
| Price | $0.83 | $1.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 72.2K | ★ 99.2K |
| Earning Date | 05-05-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.65 | $0.07 |
| 52 Week High | $10.05 | $3.25 |
Technical Indicators
Market Signals| Indicator | WHLR | CMND |
|---|---|---|
| Relative Strength Index (RSI) | 26.57 | 62.15 |
| Support Level | N/A | $0.99 |
| Resistance Level | $2.25 | $2.76 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 3.73 | 84.49 |
Price Performance
Historical ComparisonAbout WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Cypress Shopping Center in Boiling Springs, South Carolina, and others.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.